Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
We are a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Dan Bowers | dan.bowers@bms.com
At Janssen, we're creating a future where disease is a thing of the past. We're the Pharmaceutical Companies of Johnson & Johnson, working for patients everywhere fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart.
Contact Us:
Megan Duke | MDuke2@ITS.JNJ.com
Ron Pendleton | RPendle1@its.jnj.com
Blair Funk | sfunk@its.jnj.com
Julio Galindo | jgalin14@its.jnj.com
Regeneron is a leading biotechnology company that invents medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments, almost all of which were homegrown in our laboratories.
About Sanofi: We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Contact Us:
Jason Bosher, Medical Specialist II
jason.bosher@regeneron.com | 757-807-5335
Teri Freesmeier | teri.freesmeier@sanofi.com
Please click the link below to learn about DUPIXENT® (dupilumab)!
https://www.dupixenthcp.com/
Krystal Biotech, Inc. is a clinical-stage gene therapy company using its proprietary Skin TARgeted Delivery (STAR-D) platform to develop effective and innovative treatments for skin diseases. While we are initially developing topical and intradermal “off-the-shelf” novel therapies for rare and orphan dermatological indications, we are expanding the use of our pioneering STAR-D technology to target and treat other skin conditions as well.
Contact Us:
Latda Philavanh | Lphilavanh@krystalbio.com
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas. For more information about AbbVie, please visit us at www.abbvie.com Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
Contact Us:
Greg McCarthy
Territory Manager
US Immunology-Dermatology
AbbVie, Inc.
CELL (804) 399-7308
OFFICE (804) 389-1163
EMAIL greg.mccarthy@abbvie.com
Blueprint Medicines aims to make real the promise of precision therapy to improve and extend life for as many people with cancer and hematologic disorders as possible.
Contact Us:
Kathy Ann Pentrack - kpentrack@blueprintmedicines.com
Deb Hartman - dhartman@blueprintmedicines.com
Castle Biosciences is a leading diagnostics company improving health through innovative tests that guide patient care. DecisionDx®-Melanoma predicts risk of recurrence or metastasis. DecisionDx®-SCC accurately identifies risk of metastasis in high-risk squamous cell carcinoma (SCC) patients with one or more risk factors.
Additionally, we have active research and development programs for tests in other diseases with high clinical need, including its test in development to predict systemic therapy response in patients with moderate-to-severe psoriasis, atopic dermatitis, and related conditions.
Contact Us:
Renee Thomas | rthomas@castlebiosciences.com
Melissa Chrapek | mchrapek@castlebiosciences.com
Shannon Dodd | sdodd@castlebiosciences.com
MJ Zwarycz | mzwarycz@castlebiosciences.com
Novartis is a leading global medicines company, using innovative science and digital technologies to create treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world. Find out more at https://www.novartis.us
We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place. It was Charles Pfizer’s vision at the beginning and it holds true today.
Contact Us:
Matthew Gulley | matthew.gulley@pfizer.com
Sydney Sanderson | sydney.sanderson@pfizer.com
Tom Keyes | Thomas.keyes@pfizer.com
At UCB, we come together everyday laser-focused on a simple question: How will this create value for people living with severe diseases? We are a global biopharmaceutical company committed to innovation to improve the lives of people with neurological and immunological diseases, finding solutions to meet their unique needs.
Contact Us:
Sallie Cooke | Sallie.Cooke@ucb.com
Jeffrey Ruhland | Jeffrey.Ruhland@ucb.com
Committed to Excellence. Delivering World-Class Service and Expertise in Molecular Diagnostics + Anatomical Pathology
Contact Us:
Darlan Bandeira | dbandeira@vikorscientific.com
Beth Midkiff | bmidkiff@vikorscientific.com
Heather McCall | hmccall@vikorscientific.com
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Contact Us:
Hope Tanner | hshope@amgen.com
Holly Van Auken | hvanauke@amgen.com
Sara Ballout | sballout@amgen.com
Arcutis Biotherapeutics champions innovation that addresses unmet patient needs—solving the everyday medical dermatology challenges that significantly impact patients and their families. With a passion for understanding what really matters to patients and healthcare providers, Arcutis leverages extensive dermatology development expertise to meaningfully advance the treatment of immune-mediated skin diseases.
Contact Us:
Tom Pollard | tpollard@arcutis.com
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma and Animal Health. Learn more at www.boehringer-ingelheim.com.
Contact Us:
Allison Walega, allison.walega@boehringer-ingelheim.com
Pia Shawa, pia.shawa@boehringer-ingelheim.com
Helsinn is a global biopharma company focused on addressing unmet needs in cancer. It has a commercial portfolio of cancer therapeutic and supportive care products underpinning the business as it progresses the research and development with an innovative pipeline of highly innovative oncology assets, building its fully integrated targeted therapies (Helsinn’s FITT strategy). Helsinn is guided by core values of respect, integrity and quality and the Group plays an active role in promoting social transformation in favor of people and the environment.
Contact Us:
Shanon Walker
Senior Sales Representative
908-633-3666
HILL DERMACEUTICALS, Inc. is a privately-owned pharmaceutical company that develops and manufactures innovative dermatology products for children and adults. We provide unique products that enhance the treatment of difficult-to-treat diseases such as scalp psoriasis, atopic dermatitis/eczema, chronically itchy ears, melasma (of the face) and actinic keratosis (pre-cancerous skin conditions).
Contact Us:
Lynnda Blane | lynnda.blane@hilldermpharmacy.com
It’s behind everything we do. An ambition to help you understand, enjoy & feel at home in your own skin. To end up seeing the magic in every wrinkle, every stretch mark. We use almost half a century of European skin and sun care expertise to help get you there. With effective formulas based on cutting-edge science, infused with a love for self-care, we accompany you on your journey.
Jeff Seals | jeff.seals@isdin.com
The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world.
Contact Us:
Kevin Feese | kevin.feese.up@kyowakirin.com
LEO Pharma Inc. is the US affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology. LEO Pharma products have been available in the US since 1994, and the company opened its US affiliate in January 2010. The company’s offices are located in Madison, NJ.
Contact Us:
Vera Hwang - vehwa@leo-pharma.com
Tyler McKee - tymck@leo-pharma.com
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world.
Contact Us:
Nicole Bullano Giles ngiles@lilly.com
Whitney Whitmore wwhitmore@lilly.com
Jennifer Totten totten_jennifer_l@lilly.com
LA ROCHE-POSAY: Recommended by 90,000 dermatologists worldwide, La Roche-Posay’s mission is to offer life-changing dermatological skincare. Created by a French pharmacist in 1975, the brand is now available in over 60 countries. It offers a unique range of daily skincare developed for every skin type to address various skin concerns and complement prescription treatments. At the center of the brand is the exclusive selenium-rich La Roche-Posay Thermal Spring Water, a core ingredient in its skincare formulas known for its soothing and antioxidant properties that is sourced from its Thermal Center in France, the first Dermatology Center in Europe.
CeraVe: CeraVe was founded in 2005 when experts within the dermatology community recognized the relationship between ceramides, compromised skin barrier and skin conditions like acne, eczema, psoriasis, and xerosis. Developed with dermatologists, all CeraVe products are formulated with 3 essential ceramides (1, 3, & 6-II) to help maintain and restore the skin’s natural barrier, reinforcing healthy skin for all.
Contact Us:
Barbara Irish | barbara.irish@loreal.com
Leslie Bauguss | Leslie.bauguss@loreal.com
Nobelpharma develops medications and medical devices for underserved patient populations. We develop treatments for diseases that go overlooked because of the small number of patients affected.
Contact Us:
Michele Wendell
Key Accounts Mid-Atlantic
240-749-5501/410-262-0909
michele.wendell@nobelpharma-us.com
At PNC, we differentiate ourselves by offering experienced and dedicated healthcare bankers that perform a complete financial services review before offering solutions. PNC Healthcare Business Banking offers revenue cycle management solutions, specialty lending for buy-outs, buy-ins, commercial real estate, equipment financing, technology, practice expansion, and debt refinance.
Contact Us:
Carmen DeCastro | carmen.decastro@pnc.com
Pamela Walker | pamela.walker@pnc.com
PRW Laboratories is central Virginia’s premier, full-service dermatopathology laboratory, now in partnership with Versant Diagnostics, a national network of subspecialized physicians! With their team of board-certified dermatopathologists, PRW Laboratories has provided diagnosic excellence to Viriginia's physicians and beyond since 2011! PRW Laboratories continues to expand their diagnostic services, consultations, and teaching through the implementation of Versant’s digital infrastructure.
Contact Us:
Rebekah Dennison | rdennison@prwlaboratories.com
John Horton | john@versantdx.com
Spencer Branson | spencer@versantdx.com
Sagis is committed to delivering the highest quality individualized diagnostic services to our physician clients and patients. Our board-certified and subspecialty-trained pathologists employ their expertise to ensure the most accurate diagnosis is provided quickly in clear and concise reports.
Contact Us:
Reagan Roseberry | rroseberry@sagisdx.com
Instagram: @sagisdx Facebook: Sagis DX
Sun Dermatology (the branded dermatology division of Sun Pharmaceutical Industries Inc. in the United States) is committed to expanding its dermatology portfolio to bring more treatment options and ongoing support for healthcare providers and patients. For more than 30 years, it has been dedicated to advancing the science of dermatology for a variety of conditions. Sun Pharmaceutical Industries Ltd., along with its subsidiaries, is ranked second in dermatology prescription volume within the U.S. per IQVIA.
Contact Us:
Jen Allen | jennifer.allen@sunpharma.com
Courtney Perini | courtney.perini@sunpharma.com
Joseph Saunders | joseph.saunders@sunpharma.com
Verrica Pharmaceuticals is a dermatology therapeutics company. YCANTH™, Verrica's lead asset, was recently approved by the FDA as the only molluscum therapy available. Physicians, patients and caregivers have long sought a safe and effective FDA approved treatment for molluscum. Molluscum, which primarily affects children, is highly contagious and is commonly transmitted in households, schools, swimming pools and other extra-curricular settings. Since molluscum spreads through skin-to-skin contact and the sharing of contaminated objects with its viral lesions, a topical treatment with precise administration is essential towards preventing further transmission. Based on the results from Verrica’s clinical trials, the FDA found that YCANTH™ is safe and effective for patients as young as two years old, providing an important treatment option for patients and caregivers struggling with this disease.”
Contact Us:
Kim Mack | kmack@verrica.com
Courtney Jordan | cjordan@verrica.com
Copyright © 2024 Virginia Dermatology Society - All Rights Reserved.